FilingReader Intelligence
Neuland Laboratories reports Q1 results, reappoints director
July 31, 2025 at 10:59 AM UTC•By FilingReader AI
Neuland Laboratories Limited reported standalone total income of ₹30,060.86 lakhs for the quarter ended June 30, 2025, with profit before tax of ₹1,737.80 lakhs. Consolidated profit before tax reached ₹1,757.04 lakhs on the same revenue.
The company also re-appointed Dr. Ravi Shankar Gopinath as an independent director for a five-year term starting August 1, 2025, subject to shareholder approval.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
BSE:NEULANDLAB•Bombay Stock Exchange
News Alerts
Get instant email alerts when Neuland Laboratories Limited. publishes news
Free account required • Unsubscribe anytime